Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Durant

Showing results (151-160 of 234) with videos related to

Pageof 24
Sort By:
The Journal of Eukaryotic Microbiology|December 16, 2006
Inflammatory cells are sources of polyamines that induce alveolar macrophage to undergo apoptosis during Pneumocystis pneumoniaChung-Ping Liao, Mark E Lasbury, Shao-Hung Wang, et al.
Bulletin of Volcanology|July 21, 2015
Spatial analysis of Mount St. Helens tephra leachate compositions: implications for future sampling strategiesP M Ayris, P Delmelle, B Pereira, et al.
The Journal of Eukaryotic Microbiology|December 16, 2006
Alterations in surfactant protein A form and clearance during Pneumocystis pneumoniaMark E Lasbury, Pamela J Durant, Shao-Hung Wang, et al.
British Journal of Pharmacology|July 2, 2010
The pharmacology of cimetidine, a new histamine H2-receptor antagonist. 1975R W Brimblecombe, W A M Duncan, G J Durant, et al.
Microbes and Infection|April 11, 2008
Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumoniaShao-Hung Wang, Chen Zhang, Mark E Lasbury, et al.
The Journal of Eukaryotic Microbiology|December 16, 2006
Expression and activation of complement protein and alveolar damage during Pneumocystis pneumoniaMark E Lasbury, Pamela J Durant, Dennis Tschang, et al.
The Journal of Eukaryotic Microbiology|December 16, 2006
Caspase-9 as a target for Pneumocystis pneumonia therapyMark E Lasbury, Shao-Hung Wang, Chen Zhang, et al.
The Journal of Antimicrobial Chemotherapy|January 3, 2012
Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trialG Fätkenheuer, C Duvivier, A Rieger, et al.
JAMA Network Open|August 13, 2024
Acute Kidney Injury in Hospitalized Patients With Exertional RhabdomyolysisAmir H Sabouri, Brian Yurgionas, Sara Khorasani, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Identification and characterization of a potential ischemia-selective N-methyl-D-aspartate (NMDA) receptor ion-channel blocker, CNS 5788S Padmanabhan, M E Perlman, L Zhang, et al.
Pageof 24

Showing results (151-160 of 234) with videos related to

Sort By:
Pageof 24
The Journal of Eukaryotic Microbiology|December 16, 2006
Inflammatory cells are sources of polyamines that induce alveolar macrophage to undergo apoptosis during Pneumocystis pneumoniaChung-Ping Liao, Mark E Lasbury, Shao-Hung Wang, et al.
Bulletin of Volcanology|July 21, 2015
Spatial analysis of Mount St. Helens tephra leachate compositions: implications for future sampling strategiesP M Ayris, P Delmelle, B Pereira, et al.
The Journal of Eukaryotic Microbiology|December 16, 2006
Alterations in surfactant protein A form and clearance during Pneumocystis pneumoniaMark E Lasbury, Pamela J Durant, Shao-Hung Wang, et al.
British Journal of Pharmacology|July 2, 2010
The pharmacology of cimetidine, a new histamine H2-receptor antagonist. 1975R W Brimblecombe, W A M Duncan, G J Durant, et al.
Microbes and Infection|April 11, 2008
Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumoniaShao-Hung Wang, Chen Zhang, Mark E Lasbury, et al.
The Journal of Eukaryotic Microbiology|December 16, 2006
Expression and activation of complement protein and alveolar damage during Pneumocystis pneumoniaMark E Lasbury, Pamela J Durant, Dennis Tschang, et al.
The Journal of Eukaryotic Microbiology|December 16, 2006
Caspase-9 as a target for Pneumocystis pneumonia therapyMark E Lasbury, Shao-Hung Wang, Chen Zhang, et al.
The Journal of Antimicrobial Chemotherapy|January 3, 2012
Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trialG Fätkenheuer, C Duvivier, A Rieger, et al.
JAMA Network Open|August 13, 2024
Acute Kidney Injury in Hospitalized Patients With Exertional RhabdomyolysisAmir H Sabouri, Brian Yurgionas, Sara Khorasani, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Identification and characterization of a potential ischemia-selective N-methyl-D-aspartate (NMDA) receptor ion-channel blocker, CNS 5788S Padmanabhan, M E Perlman, L Zhang, et al.
Pageof 24